The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 30.40
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 2.00 (6.803%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 30.40
MIG5 Live PriceLast checked at -
Maven Income and Growth VCT 5 is an Investment Trust

To invest in a diversified portfolio of later-stage UK private companies to provide long-term capital appreciation and generate maintainable levels of income for shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Financial Report

6 Mar 2017 18:12

RNS Number : 6732Y
Maven Income and Growth VCT 5 PLC
06 March 2017
 

Maven Income and Growth VCT 5 PLC

 

Final results for the year ended 30 November 2016

 

The Directors report the Company's financial results for the year ended 30 November 2016

 

Highlights for the Year

 

• NAV total return of 71.67p per share (2015: 71.47p) at the year end

 

• NAV at year end of 38.92p per share (2015: 41.42p) after payment of dividends totalling 2.70p during the year

 

• Four new private equity investments added to the portfolio

 

• Strong pipeline of qualifying private equity investments, with a number in advanced progress

 

• Realisation of Westway Services Holdings for a total return of 3.6 times cost

 

• Exit from Dantec Hose, generating a total return of 2.1 times cost

 

• A total of £1,651,000 of proceeds realised from AIM disposals

 

• AIM concentration reduced to 30% of net assets

 

• Annual dividend maintained at 2.65p per share

 

STRATEGIC REPORT

 

Chairman's Statement

 

On behalf of your Board, I am pleased to announce the results for the year to 30 November 2016. During the period under review, NAV total return increased to 71.67p per share. Since Maven's appointment as Manager in 2011, the NAV total return per share has progressed from 52.24p to 71.67p, an increase of 37.19%. This steady performance demonstrates the progressive implementation of the investment strategy which has the primary objective of delivering consistent Shareholder returns by rebalancing the portfolio towards private equity investments with a reduction in the exposure to AIM. The Board is proposing a final dividend of 1.70p per share, bringing the full year dividend to 2.65p per share.

 

The period under review has been one of considerable change for the UK VCT industry following the introduction of the revised VCT legislation, which was enacted in November 2015. The new rules have introduced a number of restrictions on the types of transactions and companies in which VCTs can invest, requiring the Manager to focus on the provision of development capital, or investing in businesses with growth finance requirements, rather than management buy-outs or acquisition based transactions which have traditionally offered a more stable return profile. The revised legislation has also introduced limitations on the ability of VCTs to participate in AIM investments, owing to the restrictions imposed by the new rules on a VCT's ability to finance acquisitions in order to retain qualifying status, which has the potential to curb a quoted company's growth ambition should it wish to expand. On this basis, and consistent with the investment strategy, no new AIM investments have been completed during the reporting period and the proportion of the portfolio invested in AIM has reduced to 30% of net assets, from 34% in 2015 and 84% in 2011 when Maven was appointed as Manager. The strategy remains to further reduce the AIM portfolio, subject to suitable market conditions and appropriate liquidity.

 

The investment team at Maven is highly experienced at sourcing and executing transactions that meet the revised qualification criteria, and the Board is encouraged by the manner in which the Manager has adapted to these changes, as demonstrated by the four new qualifying investments completed during the reporting period. The Directors are also aware that there is a large and diverse pipeline of prospective new investments, at various stages of the diligence process, and anticipate seeing a number of these transactions complete during the first half of the current financial year. The Board is pleased to report that two further investments completed shortly after the period end, details of which can be found in the Investment Manager's Review in the Annual Report.

 

The Board believes that considerable progress has been achieved by your Company during the reporting period notwithstanding the challenges presented by the implementation of the revised legislation, the economic uncertainty introduced following the European Union (EU) referendum in June 2016 and the ongoing impact of the low oil price. Notable highlights include the completion of four new qualifying private equity investments and a number of profitable realisations, including the exit from Westway Services Holdings in December 2015, achieving a return of 3.6 times cost over the period of investment, and Dantec Hose in February 2016, achieving a 2.1 times return. The Board is aware that discussions are in progress regarding a number of potential exits from several of the more mature portfolio companies, although there can be no certainty that these will lead to profitable realisations.

 

The portfolio has traded well during the period, as can be seen from the detailed analysis of the portfolio developments included in the Investment Manager's review. The continuing growth experienced by a number of private company holdings has enabled the values of these assets to be increased, reflecting positive trading results. The Board remains conscious of the impact that the low oil price is having on companies with exposure to this sector.

Whilst direct remedial action has been taken by investee companies with exposure to the oil & gas market, the ongoing impact of the external environment remains challenging, and is expected to remain so until at least the second half of 2017. As such, the valuations of a number of these investments have been reduced to reflect the market conditions.

 

Whilst the full impact of the UK's decision to leave the EU will become clearer once formal negotiations commence, the Board and the Manager have conducted a review of the portfolio and, at present, believe that any overall impact is not likely to be significant. The businesses in which your Company has invested will maintain or adapt their growth strategies as appropriate, with a number of exporters already seeing a short-term benefit from the devaluation of Sterling against several major currencies that has occurred since the EU referendum in June 2016.

 

Dividends

 

The Board recommends that a final dividend of 1.70p per Ordinary Share, comprising 0.20p of revenue and 1.50p of capital, be paid on 28 April 2017 to Shareholders on the register on 31 March 2017. This would bring total dividends for the year to 2.65p per share representing a yield of 7.31% based on the year-end closing mid-market share price of 36.25p. The effect of paying the proposed final dividend would be to reduce the NAV of the Company by the total cost of the distribution.

 

Since the Company's launch, and after receipt of the proposed final dividend, Shareholders will have received 34.45p per share in tax-free dividends. However, the Board considers it important that Shareholders are aware that the move to support younger or earlier stage businesses, enforced by the change in VCT legislation, may result in less predictable capital gains and income flows, with the result that the quantum and timing of future dividend payments is likely to be subject to fluctuation.

 

Fund Raising

 

As your Company currently enjoys significant cash liquidity available for new investment, the Board has elected not to raise further funds at present.

 

Share Buy-backs

 

Shareholders should be aware that the Board's primary objective is for the Company to retain sufficient liquid assets for making investments in line with its stated policy and for the continued payment of dividends to Shareholders. However, the Directors also acknowledge the need to maintain an orderly market in the Company's shares, and have delegated authority to the Manager to buy back shares in the market for cancellation or to be held in treasury, subject always to such transactions being in the best interests of Shareholders.

 

It is intended that, subject to market conditions, available liquidity and the maintenance of the Company's VCT status, shares will be bought back at prices representing a discount of between 10% and 15% to the prevailing NAV per share.

 

Regulatory Developments

 

As previously reported, the Finance Act (No. 2) 2015 was enacted in November 2015 and introduced a number of changes to the legislation governing VCTs. The new rules are designed to bring the UK VCT scheme into line with EU State Aid Rules for smaller company investment and have introduced a number of restrictions on the types of qualifying transactions and companies in which VCTs can invest. Unlike previous changes in legislation, the new rules apply to all funds raised by a VCT, including those raised prior to November 2015.

 

The new rules specifically prohibit participation in management buy-outs or acquisitions, and limit the ability to support older companies unless specific criteria are met. The emphasis is, therefore, on providing development capital to younger and earlier stage companies, or supporting more established businesses which can successfully demonstrate growth strategies that satisfy specific provisions under the revised qualification criteria. In a further amendment, the March 2016 Budget Statement included changes to the rules governing non-qualifying investments by VCTs. With effect from 6 April 2016, VCTs have only been able to make qualifying investments and certain limited investments for liquidity purposes, with other types of new non-qualifying investments now prohibited.

 

The revised legislation has imposed additional diligence requirements and administrative hurdles on the investment process to ensure that all aspects of the potential investment and transaction structure remain compliant with the new rules. The Manager continues to pursue a cautious approach, working closely with a specialist VCT adviser, engaged by the Company, to assist in interpreting the revised legislation and advising on the VCT tax clearance process with HM Revenue & Customs (HMRC) to ensure that advance assurance is obtained prior to any new investment proceeding. The Board welcomed the announcement in the Chancellor's 2016 Autumn Statement that, in response to the increased volume of applications submitted and the resultant delays experienced in obtaining clearance for proposed investments, a consultation is to be carried out to consider the options for streamlining the HMRC advance assurance service.

 

The 2016 Autumn Statement highlighted that the Government will no longer be initiating a review into the provision to allow replacement capital in certain new VCT transactions, but suggested that this may be reviewed at some point in the future. Whilst the Directors and the Manager were disappointed by this announcement, as the ability to include replacement capital was viewed as an important flexibility under the new rules, it does not impact the Company's investment strategy which has already been adapted to meet the requirements of the new rules.

 

Annual General Meeting (AGM)

 

As Shareholders are aware, AGMs have been held in Glasgow and London in alternate years in order to allow a wide range of Shareholders the opportunity to meet the Directors and the Manager. The 2017 AGM will be held in the London office of Maven Capital Partners UK LLP on 25 April 2017 and the Notice of Annual General Meeting can be found in the Annual Report.

 

As Shareholders are aware, following a formal tender process, Deloitte LLP were appointed as auditor to the Company with effect from 9 September 2016. Shareholders will be asked to confirm their appointment at the forthcoming AGM.

 

The Future

 

The past year has been one of transition for your Company as the Manager has adapted its investment approach to meet the requirements of the new VCT rules. The Directors are encouraged by the progress achieved during the year, particularly noting the six new investments which have completed to date, and believe that the outlook for the forthcoming year is positive given the strength of the existing portfolio and the pipeline of new opportunities currently in process. The Board believes that these new investments, together with potential realisations from the underlying portfolio, will enable your Company to continue to meet its investment objective and deliver sustainable growth in Shareholder returns for the foreseeable future.

 

 

Allister Langlands

Chairman

6 March 2017

 

 

Business Report

 

This Business Report is intended to provide an overview of the strategy and business model of the Company as well as the key measures used by the Directors in overseeing its management. The Company is a venture capital trust which invests in accordance with the investment objective set out in this Business Report.

 

Investment Objective

 

The Company aims to achieve long-term capital appreciation and generate maintainable levels of income for Shareholders. Maven Capital Partners UK LLP (Maven or the Manager) was appointed in February 2011 with a view to applying a new investment policy, as set out below, and changing the focus of the portfolio from AIM/ISDX quoted companies to unquoted private company investments.

 

Business Model and Investment Policy

 

Under an investment policy approved by the Directors, the Company intends to achieve its objective by:

 

• investing the majority of its funds in a diversified portfolio of shares and securities in smaller, unquoted UK companies and AIM/ISDX quoted companies which meet the criteria for VCT qualifying investments and have strong growth potential;

• investing no more than £1 million in any company in one year and no more than 15% of the Company's assets by cost in one business at any time; and

• borrowing up to 15% of net asset value, if required and only on a selective basis, in pursuit of its investment strategy. The Board has no intention of approving any borrowing at this time.

 

Principal Risks and Uncertainties

 

The principal risks and uncertainties facing the Company are as follows:

 

Investment Risk

 

Many of the Company's investments are in small and medium sized unquoted UK companies and AIM/ISDX quoted companies which, by their nature, entail a higher level of risk and lower liquidity than investments in large quoted companies. The Board aims to limit the risk attaching to the investment portfolio as a whole by ensuring that a robust structured selection, monitoring and realisation process is applied. The Board reviews the investment portfolio with the Manager on a regular basis.

 

The Company manages and minimises investment risk by:

 

• diversifying across a large number of companies;

• diversifying across a range of economic sectors;

• actively and closely monitoring the progress of investee companies;

• seeking to appoint a non-executive director to the board of each private investee company, provided from the Manager's investment management team or from its pool of experienced independent directors;

• co-investing with other clients of the Manager in larger deals, which tend to carry less risk;

• not investing in hostile public to private transactions; and

• retaining the services of a manager that can provide the resources required to achieve the investment objective and meet the criteria stated above.

 

Financial and Liquidity Risk

 

As most of the investments require a mid to long-term commitment and are relatively illiquid, the Company retains a portion of the portfolio in cash and listed investments in order to finance any new unquoted investment opportunities. The Company has only limited direct exposure to currency risk and does not enter into any derivative transactions.

 

Economic Risk

 

The valuation of investment companies may be affected by underlying economic conditions such as fluctuating interest rates and the availability of bank finance.

 

Credit Risk

 

The Company may hold financial instruments and cash deposits and is dependent on counterparties discharging their agreed responsibilities. The Directors consider the creditworthiness of the counterparties to such instruments and seek to ensure that there is no undue concentration of exposure to any one party.

 

Internal Control Risk

 

The Board reviews regularly the system of internal controls, both financial and non-financial, operated by the Company and the Manager. These include controls designed to ensure that the Company's assets are safeguarded and that all records are complete and accurate.

 

VCT Qualifying Status Risk

 

The Company operates in a complex regulatory environment and faces a number of related risks, including:

• becoming subject to capital gains tax on the sale of its investments as a result of a breach of Section 274 of the Income Tax Act 2007;

• loss of VCT status and the consequential loss of tax reliefs available to Shareholders as a result of a breach of the VCT regulations;

• loss of VCT status and reputational damage as a result of a serious breach of other regulations such as the FCA Listing Rules and the Companies Act 2006; and

• increased investment restrictions resulting from the EU State Aid Rules enacted through the Finance Act (No. 2) 2015.

 

Legislative and Regulatory Risk

 

In order to maintain its approval as a VCT, the Company is required to comply with current VCT legislation in the UK as well as the EU State Aid Rules. Changes to either legislation could have an adverse impact on Shareholder investment returns whilst maintaining the Company's VCT status. The Board and the Manager continue to make representations where appropriate, either directly or through relevant industry bodies such as the Association of Investment Companies (AIC) and the British Venture Capital Association (BVCA).

 

The Company has retained Philip Hare & Associates LLP as VCT advisers.

 

Breaches of other regulations, including but not limited to, the Companies Act 2006, the FCA Listing Rules, the FCA Disclosure and Transparency Rules or the Alternative Investment Fund Managers Directive (the AIFMD), could lead to a number of detrimental outcomes and reputational damage.

 

The AIFMD, which regulates the management of alternative investment funds, including VCTs, introduced a new authorisation and supervisory regime for all investment companies in the EU. The Board is approved by the FCA as a self-managed small registered UK AIFM under the AIFMD.

 

The Company is also required to comply with tax legislation under the Foreign Account Tax Compliance Act and the Common Reporting Standard. The Company has appointed Capita Asset Services to act on its behalf to report annually to HMRC and ensure compliance with this legislation.

 

Political Risk

 

In a referendum held on 23 June 2016, the UK voted to leave the EU (informally known as "Brexit"). The formal process of implementing this decision is governed by Article 50 of the Lisbon Treaty. The political, economic and legal consequences of the referendum vote are not yet known. It is possible that investments in the UK may be more subjective to value, may be more difficult to assess for suitability of risk, harder to buy or sell or may be subject to greater or more frequent rises and falls in value. In the longer term, there is likely to be a period of uncertainty as the UK seeks to negotiate its exit from the EU. The UK's laws and regulations concerning funds may in future diverge from those of the EU. This may lead to changes in the operation of the Company or the rights of investors or the territories in which the shares of the Company may be promoted and sold.

 

An explanation of certain economic and financial risks and how they are managed is also contained in Note 16 to the Financial Statements.

 

Statement of Compliance with Investment Policy

 

The Company is adhering to its stated investment policy and managing the risks arising from it. This can be seen in various tables and charts throughout the Annual Report, from information provided in the Chairman's Statement and in the Investment Manager's Review. A review of the Company's business, its position as at 30 November 2016 and its performance during the year then ended is included in the Chairman's Statement, which also includes an overview of the Company's business model and strategy.

 

The management of the investment portfolio has been delegated to Maven, which also provides company secretarial, administrative and financial management services to the Company. The Board is satisfied with the depth and breadth of the Manager's resources and its network of offices which supply new deals and enable it to monitor the geographically widespread portfolio of companies effectively.

 

The Investment Portfolio Summary contained within the Annual Report discloses the investments in the portfolio and the degree of co-investment with other clients of the Manager. The tabular analysis of the unlisted and quoted portfolio contained within the Annual Report shows that the portfolio is diversified across a variety of industry sectors and deal types. The level of VCT qualifying investment is monitored by the Manager on a daily basis and reported to the Risk Committee quarterly.

 

Key Performance Indicators

 

At each Board Meeting the Directors consider a number of financial performance measures to assess the Company's success in achieving its objectives, and these also enable Shareholders and prospective investors to gain an understanding of its business. The key performance indicators are as follows:

 

• NAV total return;

• dividend growth;

• share price discount to NAV;

• the progress being made on the transition of the legacy AIM portfolio to one focused on new unquoted investments;

• investment income; and

• operational expenses.

 

The NAV total return is a measure of Shareholder value that includes both the current NAV per share and the sum of dividends paid to date. The dividend growth measure shows how much of that Shareholder value has been returned to original investors in the form of dividends. A historical record of these measures is shown in the Financial Highlights in the Annual Report and the profile of the portfolio is reflected in the Summary of Investment Changes in the Annual Report. The Board reviews the Company's investment income and operational expenses on a quarterly basis as the Directors consider that both of these elements are important components in the generation of Shareholder returns.

 

There is no meaningful VCT index against which to compare the financial performance of the Company but, for reporting to the Board and Shareholders, the Manager uses comparisons with appropriate indices and the Company's peer group. The Directors also consider non-financial performance measures such as the flow of investment proposals and the Company's ranking within the VCT sector by independent analysts.

 

In addition, the Directors consider economic, regulatory and political trends and features that may impact on the Company's future development and performance.

 

Valuation Process

 

Investments held by Maven Income and Growth VCT 5 PLC in unquoted companies are valued in accordance with the International Private Equity and Venture Capital Valuation Guidelines. Investments quoted or traded on a recognised stock exchange, including AIM, are valued at their bid prices.

 

Share Buy-backs

 

The Board will seek the necessary Shareholder authority to continue to conduct a share buy-back programme under appropriate circumstances.

 

Employee, Environmental and Human Rights Policy

 

The Company has no direct employee or environmental responsibilities, nor is it responsible for the emission of greenhouse gases. The Board's principal responsibility to Shareholders is to ensure that the investment portfolio is managed and invested properly. The Company has no employees and, accordingly, has no requirement to report separately on employment matters. The management of the portfolio is undertaken by the Manager through members of its portfolio management team. The Manager engages with the Company's underlying investee companies in relation to their corporate governance practices and in developing their policies on social, community and environmental matters and further information may be found in the Statement of Corporate Governance in the Annual Report. In light of the nature of the Company's business, there are no relevant human rights issues and, therefore, the Company does not have a human rights policy.

 

Auditor

 

The Company's Auditor is required to report if there are any material inconsistencies between the content of the Strategic Report and the Financial Statements. The Independent Auditor's Report can be found in the Annual Report.

 

Future Strategy

The Board and Manager intend to maintain the policies set out above for the year ending 30 November 2017 as it is believed that these are in the best interests of Shareholders.

 

Approval

 

The Business Report, and the Strategic Report as a whole, was approved by the Board of Directors and signed on its behalf by:

 

 

 

Allister Langlands

Director

6 March 2017

 

 

 

Maven Income and Growth VCT 5 PLC

Income Statement

For the Year Ended 30 November 2016

 

Year ended 30 November 2016

Year ended 30 November 2015

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Gains on investments

-

311

311

-

3,581

3,581

Income from investments

779

-

779

830

-

830

Other income

3

-

3

-

-

-

Investment management fees

(162)

(488)

(650)

(175)

(524)

(699)

Other expenses

(295)

-

(295)

(224)

-

(224)

Net return on ordinary activities before taxation

325

(177)

148

431

3,057

3,488

Tax on ordinary activities

(57)

57

-

(68)

68

-

Return attributable to Equity Shareholders

268

(120)

148

363

3,125

3,488

 

Earnings per share (pence)

 

0.35

 

(0.16)

 

0.19

 

0.48

 

4.16

 

4.64

 

All gains and losses are recognised in the Income Statement.

 

All items in the above statement are derived from continuing operations. The Company has only one class of business and one reportable segment, the results of which are set out in the Income Statement and Balance Sheet. The company derives its income from investments made in shares, securities and bank deposits.

 

There are no potentially dilutive capital instruments in issue and therefore no diluted returns per share figures are relevant. The basic and diluted earnings per share are therefore identical.

 

The total column of this Statement is the Profit and Loss Account of the Company.

 

 

Maven Income and Growth VCT 5 PLC

Statement of Changes in Equity

For the Year Ended 30 November 2016

 

 

 

 

 

 

Share

Capital

£'000

Share

premium

account

£'000

Capital

reserve

realised

£'000

Capital

reserve

unrealised

£'000

Special

distributable

reserve

£'000

Capital redemption

reserve

£'000

 

Revenue reserve

£'000

 

 

Total

£'000

At 30 November 2015

7,734

8,816

(20,515)

(4,663)

38,219

3,545

(1,104)

32,032

Net return

-

-

756

(876)

-

-

268

148

Dividends paid

-

-

(1,778)

-

-

-

(309)

(2,087)

Repurchase and cancellation of shares

(23)

-

-

-

(82)

23

-

(82)

At 30 November 2016

7,711

8,816

(21,537)

(5,539)

38,137

3,568

(1,145)

30,011

 

 

For the Year Ended 30 November 2015

 

 

 

 

 

Share

Capital

£'000

Share premium account

£'000

Capital reserve realised

£'000

Capital reserve unrealised

£'000

Special distributable

reserve

£'000

Capital redemption

reserve

£'000

 

Revenue reserve

£'000

 

 

Total

£'000

At 30 November 2014

6,760

5,840

(19,779)

(6,663)

38,350

3,506

(1,312)

26,702

Net return

-

-

1,125

2,000

-

-

363

3,488

Dividends paid

-

-

(1,861)

-

-

-

(155)

(2,016)

Repurchase and cancellation of shares

(39)

-

-

-

(131)

39

-

(131)

Share issue

1,013

2,976

-

-

-

-

-

3,989

At 30 November 2015

7,734

8,816

(20,515)

(4,663)

38,219

3,545

(1,104)

32,032

 

The accompanying Notes are an integral part of the Financial Statements.

 

 

 

BALANCE SHEET

As at 30 November 2016

 

 

 

 

30 November 2016

£'000

30 November 2015

£'000

Fixed assets

 

26,077

 

30,488

Investments at fair value through profit or loss

 

Current assets

Debtors

210

168

Cash

4,103

1,717

 

Creditors

4,313

1,885

Amounts falling due within one year

(379)

(341)

Net current assets

3,934

1,544

Net assets

30,011

32,032

 

 

 

Capital and reserves

 

 

 

 

7,711

 

 

 

 

7,734

Called up share capital

Share premium account

8,816

8,816

Capital reserve - realised

(21,537)

(20,515)

Capital reserve - unrealised

(5,539)

(4,663)

Special distributable reserve

38,137

38,219

Capital redemption reserve

3,568

3,545

Revenue reserve

(1,145)

(1,104)

Net assets attributable to Ordinary Shareholders

30,011

32,032

 

Net asset value per Ordinary Share (pence)

 

 

 

38.92

 

41.42

 

The Financial Statements of Maven Income and Growth VCT 5 PLC, registered number 4084875, were approved and authorised for issue by the Board of Directors on 6 March 2017 and were signed on its behalf by:

 

 

 

Allister Langlands

Director

 

The accompanying Notes are an integral part of the Financial Statements.

 

 

 

CASH FLOW STATEMENT

For the Year Ended 30 November 2016

 

Year ended 30 November 2016

£'000

Year ended 30 November 2015

£'000

Net cash flows from operating activities

(1,100)

(854)

 

Cash flows from investing activities

Investment income received

742

819

Deposit interest received

3

-

Purchase of investments

(10,478)

(22,840)

Sale of investments

15,388

21,995

Net cash flows from investing activities

5,655

(26)

 

 

Cash flows from financing activities

 

 

 

(2,087)

 

 

 

(2,016)

Equity dividends paid

Issue of Ordinary Shares

-

3,989

Repurchase of Ordinary Shares

(82)

(131)

Net cash flows from financing activities

(2,169)

1,842

Net increase in cash

2,386

962

 

 

Cash at beginning of year

 

 

1,717

 

 

755

Cash at end of year

4,103

1,717

 

The accompanying Notes are an integral part of the Financial Statements

 

 

 

NOTES TO THE FINANCIAL STATEMENTS

For the Year Ended 30 November 2016

 

1. Accounting Policies

(a) Basis of preparation

The Financial Statements have been prepared under FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland, and in accordance with the Statement of Recommended Practice for Investment Trust Companies and Venture Capital Trusts ('the SORP') issued by the Association of Investment Companies ('AIC') in November 2014.

 

(b) Income

Dividends receivable on equity shares and unit trusts are treated as revenue for the period on an ex-dividend basis. Where no ex-dividend date is available dividends receivable on or before the year end are treated as revenue for the period. Provision is made for any dividends not expected to be received. The fixed returns on debt securities and non-equity shares are recognised on a time apportionment basis so as to reflect the effective interest rate on the debt securities and shares. Provision is made for any fixed income not expected to be received. Interest receivable from cash and short term deposits and interest payable are accrued to the end of the year.

 

(c) Expenses

All expenses are accounted for on an accruals basis and charged to the income statement. Expenses are charged through the revenue account except as follows:

 

• expenses which are incidental to the acquisition and disposal of an investment are charged to capital; and

• expenses are charged to realised capital reserves where a connection with the maintenance or enhancement of the value of the investments can be demonstrated. In this respect, the investment management fee has been allocated 25% to revenue and 75% to realised capital reserves to reflect the Company's investment policy and prospective income and capital growth.

 

(d) Taxation

Deferred taxation is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date, where transactions or events that result in an obligation to pay more tax in the future or right to pay less tax in the future have occurred at the balance sheet date. This is subject to deferred tax assets only being recognised if it is considered more likely than not that there will be suitable profits from which the future reversal of the underlying timing differences can be deducted. Timing differences are differences arising between the Company's taxable profits and its results as stated in the Financial Statements which are capable of reversal in one or more subsequent periods.

 

Deferred tax is measured on a non-discounted basis at the tax rates that are expected to apply in the periods in which timing differences are expected to reverse, based on tax rates and laws enacted or substantively enacted at the balance sheet date.

 

The tax effect of different items of income/gain and expenditure/ loss is allocated between capital reserves and revenue account on the same basis as the particular item to which it relates using the Company's effective rate of tax for the period.

 

UK corporation tax is provided at amounts expected to be paid/ recovered using the tax rates and laws that have been enacted or substantively enacted at the balance sheet date.

 

(e) Investments

In valuing unlisted investments, the Directors follow the criteria set out below. These procedures comply with the revised International Private Equity and Venture Capital Valuation Guidelines (IPEVCV) for the valuation of private equity and venture capital investments. Investments are recognised at their trade date and are designated by the Directors as fair value through profit and loss. At subsequent reporting dates, investments are valued at fair value, which represents the Directors' view of the amount for which an asset could be exchanged between knowledgeable and willing parties in an arm's length transaction. This does not assume that the underlying business is saleable at the reporting date or that its current shareholders have an intention to sell their holding in the near future.

 

A financial asset or liability is generally derecognised when the contract that gives rise to it is settled, sold, cancelled or expires.

 

1. For investments completed prior to the reporting date, fair value is determined using the Price of Recent Investment Method, except that adjustments are made when there has been a material change in the trading circumstances of the company or a substantial movement in the relevant sector of the stock market.

2. Whenever practical, recent investments will be valued by reference to a material arm's length transaction or a quoted price.

3. Mature companies are valued by applying a multiple to their prospective earnings to determine the enterprise value of the company.

3.1 To obtain a valuation of the total ordinary share capital held by management and the institutional investors, the value of third party debt, institutional loan stock, debentures and preference share capital is deducted from the enterprise value. The effect of any performance related mechanisms is taken into account when determining the value of the ordinary share capital.

3.2 Preference shares, debentures and loan stock are valued using the Price of Recent Investment Method. When a redemption premium has accrued, this will only be valued if there is a reasonable prospect of it being paid. Preference shares which carry a right to convert into ordinary share capital are valued at the higher of the Price of Recent Investment Method basis and the price/earnings basis.

4. In the absence of evidence of a deterioration, or strong defensible evidence of an increase in value, the fair value is determined to be that reported at the previous balance sheet date.

5. All unlisted investments are valued individually by the portfolio management team of Maven Capital Partners UK LLP. The resultant valuations are subject to detailed scrutiny and approval by the Directors of the Company.

6. In accordance with normal market practice, investments listed on the Alternative Investment Market of the London Stock Exchange or a recognised stock exchange are valued at their bid market price.

 

(f) Fair value measurement

Fair value is defined as the price that the Company would receive upon selling an investment in a timely transaction to an independent buyer in the principal or the most advantageous market of the investment. A three-tier hierarchy has been established to maximise the use of observable market data and minimise the use of unobservable inputs and to establish classification of fair value measurements for disclosure purposes. Inputs refer broadly to the assumptions that market participants would use in pricing the asset or liability, including assumptions about risk, for example, the risk inherent in a particular valuation technique used to measure fair value including such a pricing model and/or the risk inherent in the inputs to the valuation technique. Inputs may be observable or unobservable.

 

Observable inputs are inputs that reflect the assumptions market participants would use in pricing the asset or liability based on market data obtained from sources independent of the reporting entity.

 

Unobservable inputs are inputs that reflect the reporting entity's own assumptions about the assumptions market participants would use in pricing the asset or liability based on best information available in the circumstances.

 

The three-tier hierarchy of inputs is summarised in the three broad levels listed below:

 

• Level 1 - the unadjusted quoted price in an active market for identical assets or liabilities that the entity can access at the measurement date.

• Level 2 - inputs other than quoted prices included within Level 1 that are observable (ie developed using market data) for the asset or liability, either directly or indirectly.

• Level 3 - inputs are unobservable (ie for which market data is unavailable) for the asset or liability.

 

(g) Gains and losses on investments

When the Company sells or revalues its investments during the year, any gains or losses arising are credited/charged to the Income Statement.

 

(h) Significant judgements and estimates

Disclosure is required of judgements and estimates made by the Board and the Manager in applying the accounting policies that have a significant effect on the Financial Statements. The area involving the highest degree of judgement and estimates is the valuation of unlisted investments recognised in Note 8 of the Financial Statements and as explained in Note 1(e) above.

 

 

Reserves

 

Share premium account

The share premium account represents the premium above nominal value received by the Company on issuing shares net of issue costs.

 

Capital reserves

Gains or losses on investments realised in the year that have been recognised in the Income Statement are transferred to the capital reserve realised account on disposal. Furthermore, any prior unrealised gains or losses on such investments are transferred from the capital reserve unrealised account to the capital reserve realised account on disposal. Increases and decreases in the fair value of investments are recognised in the Income Statement and are then transferred to the capital reserve unrealised account. The capital reserve realised account also represents capital dividends, capital investment management fees and the tax effect of capital items.

 

Special distributable reserve

The total cost to the Company of the repurchase and cancellation of shares is represented in the special distributable reserve account.

 

Capital redemption reserve

The nominal value of shares repurchased and cancelled is represented in the capital redemption reserve.

 

Revenue reserve

The revenue reserve represents accumulated profits retained by the Company that have not been distributed to shareholders as a dividend.

 

Return per Ordinary Share

 

The returns per share have been based on the following figures:

Year ended

30 November 2016

Year ended

30 November 2015

The returns per share have been

 

 

77,277,480

 

 

75,119,671

based on the following figures:

Weighted average number of Ordinary Shares

 

Revenue return

 

£268,000

 

£363,000

Capital return

(£120,000)

£3,125,000

Total return

£148,000

£3,488,000

 

 

Net asset value per Ordinary Share

 

The net asset value per Ordinary Share as at 30 November 2016 has been calculated using the number of Ordinary Shares in issue at that date of 77,111,087 (2015: 77,341,087).

 

Directors' responsibility statement

 

The Directors confirm that, to the best of their knowledge:

 

• the Financial Statements have been prepared in accordance with the applicable accounting standards and give a true and fair view of the assets, liabilities, financial position and profit or loss of the Company as at 30 November 2016 and for the year to that date;

• the Directors' Report includes a fair review of the development and performance of the Company, together with a description of the principal risks and uncertainties that it faces; and

• the Annual Report and Financial Statements taken as a whole is fair, balanced and understandable and provides the information necessary for Shareholders to assess the Company's position and performance, business model and strategy.

 

Other information

 

The Annual General Meeting will be held on Tuesday, 25 April 2017, commencing at 10.00am, at Maven Capital Partners UK LLP, Fifth Floor, 1-2 Royal Exchange Buildings, London EC3V 3LF.

 

Copies of this announcement, and of the Annual Report and Financial Statements for the year ended 30 November 2016, will be available to the public at the offices of Maven Capital Partners UK LLP, Kintyre House, 205 West George Street, Glasgow G2 2LW; at the registered office of the Company, Fifth Floor, 1-2 Royal Exchange Buildings, London EC3V 3LF and on the Company's website at www.mavencp.com/migvct5.

 

The Annual Report and Financial Statements for the year ended 30 November 2016 will be issued to Shareholders and filed with the Registrar of Companies in due course.

 

The financial information contained within this Announcement does not constitute the Company's statutory Financial Statements as defined in the Companies Act 2006. The statutory Financial Statements for the year ended 30 November 2015 have been delivered to the Registrar of Companies and contained an audit report which was unqualified and did not constitute statements under S498(2) or S498(3) of the Companies Act 2006.

 

Neither the content of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

 

The Annual Report will be submitted to the National Storage Mechanism and will be available for inspection at: www.morningstar.co.uk/uk/NSM 

 

 

 

 

By order of the Board

Maven Capital Partners UK LLP

Secretary

 

6 March 2017

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR JFMPTMBMMBFR
Date   Source Headline
23rd Apr 20242:27 pmRNSResult of AGM
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:49 pmRNSIssue of Equity
27th Mar 202410:31 amRNSIssue of Equity
22nd Mar 20244:25 pmRNSStatement re Offer for Subscription
22nd Mar 202410:14 amRNSIssue of Supplementary Prospectus
20th Mar 20243:48 pmRNSUnaudited Net Asset Value
8th Mar 20242:57 pmRNSAnnual Financial Report
15th Feb 20244:45 pmRNSTransaction in Own Shares
8th Feb 202410:33 amRNSDirector/PDMR Shareholding
8th Feb 202410:12 amRNSIssue of Equity
7th Feb 20243:09 pmRNSDividend Declaration
19th Dec 20233:28 pmRNSIssue of Equity
18th Dec 20235:24 pmRNSUnaudited Net Asset Value
9th Nov 20233:51 pmRNSResult of General Meeting
20th Oct 20234:13 pmRNSTransaction in Own Shares
13th Oct 20234:56 pmRNSPublication of a Prospectus
4th Oct 20234:03 pmRNSNet Asset Value(s)
29th Aug 20239:15 amRNSDirectorate Change
24th Jul 202311:16 amRNSHalf-year Report
21st Jul 20234:43 pmRNSTransaction in Own Shares
21st Jul 20239:48 amRNSIssue of Equity
17th Jul 202310:57 amRNSNet Asset Value - Dividend Investment Scheme
11th Jul 20234:47 pmRNSNet Asset Value
6th Jul 20234:01 pmRNSStatement re Intended Offers for Subscription
14th Jun 202310:33 amRNSDividend Declaration
2nd Jun 20239:48 amRNSIssue of Equity
5th May 202310:23 amRNSIssue of Equity - Dividend Investment Scheme
27th Apr 20233:57 pmRNSTransaction in Own Shares
27th Apr 20231:04 pmRNSIssue of Supplementary Prospectus
26th Apr 202311:39 amRNSNet Asset Value - Dividend Investment Scheme
25th Apr 20233:14 pmRNSNet Asset Value(s)
25th Apr 202312:50 pmRNSResult of AGM
5th Apr 202312:32 pmRNSIssue of Equity
29th Mar 20232:19 pmRNSIssue of Supplementary Prospectus
23rd Mar 20235:18 pmRNSAnnual Financial Report
3rd Mar 20239:56 amRNSIssue of Equity
21st Feb 20234:44 pmRNSTransaction in Own Shares
8th Feb 202310:24 amRNSDirector/PDMR Shareholding
8th Feb 20239:48 amRNSIssue of Equity
1st Feb 20233:25 pmRNSUnaudited NAV and Proposed Final Dividend
9th Nov 20223:02 pmRNSResult of General Meeting
4th Nov 20223:25 pmRNSTransaction in Own Shares
26th Oct 20223:53 pmRNSTransaction in Own Shares
7th Oct 20224:28 pmRNSPublication of a Prospectus
4th Oct 20223:30 pmRNSChange of Auditor
4th Oct 20221:35 pmRNSNet Asset Value(s)
26th Aug 202210:14 amRNSIssue of Equity
22nd Aug 20229:36 amRNSStatement re Dividend Investment Scheme
11th Aug 20224:47 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.